North America DNA Sequencing Market Forecast 2017-2023
KEY FINDINGS
North America has the largest market share of the DNA sequencing market. Factors, which favor growth of DNA sequencing market, are better healthcare infrastructure, awareness about latest technologies, major biotechnology companies being based in this region and government initiatives for increasing research and development. The global DNA sequencing market is poised to grow during the forecast period of 2017-2023. Various reasons for growth of the DNA sequencing market are increase in demand for noninvasive detection, disease diagnosis and personalized treatment, decreasing costs of DNA sequencing and higher research and spending by biotechnology companies.
DNA sequencing is the method of identifying the precise sequence of nucleotides present in the DNA. DNA sequencing can be carried by various technologies, which are basically biochemical methods. The nucleotides in the DNA molecule are adenosine, cytosine, guanine and thymine. A person’s DNA sequence contains information about personality traits, genetically determined illness and IQ level. This data can give the individual and physicians a very clear picture about the person’s genetic information and help in providing personalized treatment, which will be most effective. This method will have a beneficial impact on other sciences like genetics, anthropology, forensic science, archeology, biotechnology and molecular biology.
DNA sequencing market is segmented on the basis of geography, technology, application and end user. Various technologies for DNA sequencing are Sequencing by Synthesis (SBS); ION Semiconductor Sequencing; Sequencing by Ligation (SBL), Pyrosequencing, Single-Molecule Real-time Sequencing (SMRT) and other technologies. Classification on the basis of application is drug discovery, diagnosis, biomarker discovery, personalized medicine, agriculture and medical research and others. End user segments are research centers and academic & government institutes; hospitals & clinics; pharmaceutical & biotechnology companies; and, some others like NPO, agri genomics organizations, consumer genomic companies.
MARKET INSIGHTS
Market drivers for DNA sequencing are growth in demand for noninvasive detection, disease diagnosis and personalized treatment, decreasing costs of DNA sequencing and higher research and spending by biotechnology companies.
Highest demand for DNA sequencing is from research and academic institutes. It is expected that this demand will continue in the forecast period and this will be the highest growing segment. Growth will also be fuelled by personalized medicine and biomarker discovery.
Factors that will restrain market growth are faster changes in technology, increase in competition, rising complexity of diseases, issues related to public health and safety and higher research and development costs.
North America has the largest market share of the DNA sequencing market. Factors, which favor growth of DNA sequencing market, are better healthcare infrastructure, awareness about latest technologies, major biotechnology companies being based in this region and government initiatives for increasing research and development. The global DNA sequencing market is poised to grow during the forecast period of 2017-2023. Various reasons for growth of the DNA sequencing market are increase in demand for noninvasive detection, disease diagnosis and personalized treatment, decreasing costs of DNA sequencing and higher research and spending by biotechnology companies.
DNA sequencing is the method of identifying the precise sequence of nucleotides present in the DNA. DNA sequencing can be carried by various technologies, which are basically biochemical methods. The nucleotides in the DNA molecule are adenosine, cytosine, guanine and thymine. A person’s DNA sequence contains information about personality traits, genetically determined illness and IQ level. This data can give the individual and physicians a very clear picture about the person’s genetic information and help in providing personalized treatment, which will be most effective. This method will have a beneficial impact on other sciences like genetics, anthropology, forensic science, archeology, biotechnology and molecular biology.
DNA sequencing market is segmented on the basis of geography, technology, application and end user. Various technologies for DNA sequencing are Sequencing by Synthesis (SBS); ION Semiconductor Sequencing; Sequencing by Ligation (SBL), Pyrosequencing, Single-Molecule Real-time Sequencing (SMRT) and other technologies. Classification on the basis of application is drug discovery, diagnosis, biomarker discovery, personalized medicine, agriculture and medical research and others. End user segments are research centers and academic & government institutes; hospitals & clinics; pharmaceutical & biotechnology companies; and, some others like NPO, agri genomics organizations, consumer genomic companies.
MARKET INSIGHTS
Market drivers for DNA sequencing are growth in demand for noninvasive detection, disease diagnosis and personalized treatment, decreasing costs of DNA sequencing and higher research and spending by biotechnology companies.
Highest demand for DNA sequencing is from research and academic institutes. It is expected that this demand will continue in the forecast period and this will be the highest growing segment. Growth will also be fuelled by personalized medicine and biomarker discovery.
Factors that will restrain market growth are faster changes in technology, increase in competition, rising complexity of diseases, issues related to public health and safety and higher research and development costs.
1. RESEARCH SCOPE
1.1. STUDY DELIVERABLES
1.2. SCOPE OF THE STUDY MARKET AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.2. BOTTOM-UP APPROACH
2.3. TOP-DOWN APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1. MARKET DEFINITION AND SCOPE
4.2. NOVEL TECHNOLOGY: DNA SEQUENCING
4.3. KEY FINDINGS
4.4. VALUE CHAIN ANALYSIS
4.5. KEY MARKET INSIGHTS
4.6. PORTER’S FIVE FORCE MODEL
4.7. KEY BUYING CRITERIA
4.8. STRATEGIC RECOMMENDATION
4.9. STRATEGIC CONCLUSIONS
5. MARKET DETERMINANTS
5.1. MARKET DRIVERS
5.2. MARKET RESTRAINTS
5.3. MARKET OPPORTUNITIES
5.4. MARKET CHALLENGES
5.5. UNDERSTANDING CHANGING MARKET SENARIO
6. NORTH AMERICA GLOBAL DNA SEQUENCING MARKET
6.1. UNITED STATES (US) GLOBAL DNA SEQUENCING MARKET
6.2. CANADA GLOBAL DNA SEQUENCING MARKET
7. MARKET SEGMENTATION
8. BY END USER
8.1. GLOBAL DNA SEQUENCING MARKET BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
8.2. GLOBAL DNA SEQUENCING MARKET BY HOSPITALS & CLINICS
8.3. GLOBAL DNA SEQUENCING MARKET BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.4. GLOBAL DNA SEQUENCING MARKET BY OTHER END
9. TYPES OF SEQUENCING TECHNOLOGY PLATFORMS
9.1. GLOBAL DNA SEQUENCING MARKET BY ILLUMINA SYNTHESIS
9.2. GLOBAL DNA SEQUENCING MARKET BY ION SEMICONDUCTOR SEQUENCING
9.3. GLOBAL DNA SEQUENCING MARKET BY SEQUENCING BY LIGATION (SBL)
9.4. GLOBAL DNA SEQUENCING MARKET BY PYROSEQUENCING
9.5. GLOBAL DNA SEQUENCING MARKET BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
9.6. GLOBAL DNA SEQUENCING MARKET BY OTHER TECHNOLOGIES
10. BY APPLICATION
10.1. GLOBAL DNA SEQUENCING MARKET BY DIAGNOSTICS
10.2. GLOBAL DNA SEQUENCING MARKET BY DRUG DISCOVERY
10.3. GLOBAL DNA SEQUENCING MARKET BY BIOMARKER DISCOVERY
10.4. GLOBAL DNA SEQUENCING MARKET BY PERSONALIZED MEDICINE
10.5. GLOBAL DNA SEQUENCING MARKET BY AGRICULTURE & ANIMAL RESEARCH
10.6. GLOBAL DNA SEQUENCING MARKET BY OTHER APPLICATIONS
11. COMPETITIVE LANDSCAPE
11.1. MARKET SHARE ANALYSIS
11.2. TOP STRATEGIES
11.3. TOP STRATEGIES
12. COMPANY PROFILES
12.1. ADAPTIVE BIOTECHNOLOGIES, INC
12.2. AGILENT TECHNOLOGIES, INC.
12.3. APPISTRY, INC.
12.4. ASURAGEN, INC.
12.5. BGI
1.1. STUDY DELIVERABLES
1.2. SCOPE OF THE STUDY MARKET AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.2. BOTTOM-UP APPROACH
2.3. TOP-DOWN APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1. MARKET DEFINITION AND SCOPE
4.2. NOVEL TECHNOLOGY: DNA SEQUENCING
4.3. KEY FINDINGS
4.4. VALUE CHAIN ANALYSIS
4.5. KEY MARKET INSIGHTS
4.6. PORTER’S FIVE FORCE MODEL
4.7. KEY BUYING CRITERIA
4.8. STRATEGIC RECOMMENDATION
4.9. STRATEGIC CONCLUSIONS
5. MARKET DETERMINANTS
5.1. MARKET DRIVERS
5.2. MARKET RESTRAINTS
5.3. MARKET OPPORTUNITIES
5.4. MARKET CHALLENGES
5.5. UNDERSTANDING CHANGING MARKET SENARIO
6. NORTH AMERICA GLOBAL DNA SEQUENCING MARKET
6.1. UNITED STATES (US) GLOBAL DNA SEQUENCING MARKET
6.2. CANADA GLOBAL DNA SEQUENCING MARKET
7. MARKET SEGMENTATION
8. BY END USER
8.1. GLOBAL DNA SEQUENCING MARKET BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
8.2. GLOBAL DNA SEQUENCING MARKET BY HOSPITALS & CLINICS
8.3. GLOBAL DNA SEQUENCING MARKET BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.4. GLOBAL DNA SEQUENCING MARKET BY OTHER END
9. TYPES OF SEQUENCING TECHNOLOGY PLATFORMS
9.1. GLOBAL DNA SEQUENCING MARKET BY ILLUMINA SYNTHESIS
9.2. GLOBAL DNA SEQUENCING MARKET BY ION SEMICONDUCTOR SEQUENCING
9.3. GLOBAL DNA SEQUENCING MARKET BY SEQUENCING BY LIGATION (SBL)
9.4. GLOBAL DNA SEQUENCING MARKET BY PYROSEQUENCING
9.5. GLOBAL DNA SEQUENCING MARKET BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
9.6. GLOBAL DNA SEQUENCING MARKET BY OTHER TECHNOLOGIES
10. BY APPLICATION
10.1. GLOBAL DNA SEQUENCING MARKET BY DIAGNOSTICS
10.2. GLOBAL DNA SEQUENCING MARKET BY DRUG DISCOVERY
10.3. GLOBAL DNA SEQUENCING MARKET BY BIOMARKER DISCOVERY
10.4. GLOBAL DNA SEQUENCING MARKET BY PERSONALIZED MEDICINE
10.5. GLOBAL DNA SEQUENCING MARKET BY AGRICULTURE & ANIMAL RESEARCH
10.6. GLOBAL DNA SEQUENCING MARKET BY OTHER APPLICATIONS
11. COMPETITIVE LANDSCAPE
11.1. MARKET SHARE ANALYSIS
11.2. TOP STRATEGIES
11.3. TOP STRATEGIES
12. COMPANY PROFILES
12.1. ADAPTIVE BIOTECHNOLOGIES, INC
12.2. AGILENT TECHNOLOGIES, INC.
12.3. APPISTRY, INC.
12.4. ASURAGEN, INC.
12.5. BGI
LIST OF TABLES
TABLE 1 NORTH AMERICA DNA SEQUENCING MARKET BY END USER SEGMENT 2017-2023 ($ MILLIONS)
TABLE 2 TOP 3 REVENUE GENERATING SEGMENT
TABLE 3 TOP THREE COUNTRIES NORTH AMERICA DNA SEQUENCING MARKET
TABLE 4 STRATEGIES USED IN NORTH AMERICA DNA SEQUENCING MARKET
TABLE 5 ESTIMATED NEW CASES AND DEATHS DUE TO CANCER 2016
TABLE 6 WORKSHOPS AND CONFERENCES RELATED TO DNA OR NEXT GENERATION SEQUENCING
TABLE 7 NORTH AMERICA DNA SEQUENCING MARKET BY END USER 2017-2023 ($ MILLION)
TABLE 8 NORTH AMERICA DNA SEQUENCING RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 9 NORTH AMERICA DNA SEQUENCING HOSPITALS & CLINICS MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 10 NORTH AMERICA DNA SEQUENCING PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 11 NORTH AMERICA DNA SEQUENCING OTHER END-USER MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 12 NORTH AMERICA DNA SEQUENCING MARKET BY TECHNOLOGY 2017-2023 ($ MILLION)
TABLE 13 SBS (SEQUENCING BY SYNTHESIS) PARAMETERS (ILLUMINA)
TABLE 14 NORTH AMERICA ILLUMINA SYNTHESIS MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 15 ION SEMICONDUCTOR SEQUENCING PARAMETERS (ION TORRENT SEQUENCING)
TABLE 16 NORTH AMERICA ION SEMICONDUCTOR SEQUENCING MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 17 SBL (SEQUENCING BY LITIGATION) PARAMETERS (SOLID SEQUENCING)
TABLE 18 NORTH AMERICA SEQUENCING BY LIGATION (SBL) MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 19 MICROBIAL APPLICATIONS USING PYROSEQUENCING
TABLE 20 PROS AND CONS OF PYROSEQUENCING
TABLE 21 NORTH AMERICA PYROSEQUENCING MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 22 SINGLE MOLECULE REAL TIME SEQUENCING PARAMETERS (PACIFIC BIOSCIENCES)
TABLE 23 NORTH AMERICA SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 24 NORTH AMERICA OTHER TECHNOLOGIES MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 25 NORTH AMERICA DNA SEQUENCING MARKET BY APPLICATION 2017-2023 ($ MILLION)
TABLE 26 FDA-APPROVED DRUGS ALONG WITH A COMPANION DIAGNOSTIC
TABLE 27 NORTH AMERICA DNA SEQUENCING DIAGNOSTICS MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 28 NORTH AMERICA DNA SEQUENCING DRUG DISCOVERY MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 29 NORTH AMERICA DNA SEQUENCING BIOMARKER DISCOVERY MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 30 NORTH AMERICA DNA SEQUENCING PERSONALIZED MEDICINE MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 31 NORTH AMERICA DNA SEQUENCING AGRICULTURE & ANIMAL RESEARCH MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 32 NORTH AMERICA DNA SEQUENCING OTHER APPLICATIONS MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 33 NORTH AMERICA DNA SEQUENCING MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 34 DIABETES BY AGE GROUP IN CANADA IN 2014
TABLE 35 NORTH AMERICA DNA SEQUENCING MARKET 2017-2023($ MILLION)
TABLE 36 STATISTICS OF CANCER CASES IN US
TABLE 1 NORTH AMERICA DNA SEQUENCING MARKET BY END USER SEGMENT 2017-2023 ($ MILLIONS)
TABLE 2 TOP 3 REVENUE GENERATING SEGMENT
TABLE 3 TOP THREE COUNTRIES NORTH AMERICA DNA SEQUENCING MARKET
TABLE 4 STRATEGIES USED IN NORTH AMERICA DNA SEQUENCING MARKET
TABLE 5 ESTIMATED NEW CASES AND DEATHS DUE TO CANCER 2016
TABLE 6 WORKSHOPS AND CONFERENCES RELATED TO DNA OR NEXT GENERATION SEQUENCING
TABLE 7 NORTH AMERICA DNA SEQUENCING MARKET BY END USER 2017-2023 ($ MILLION)
TABLE 8 NORTH AMERICA DNA SEQUENCING RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 9 NORTH AMERICA DNA SEQUENCING HOSPITALS & CLINICS MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 10 NORTH AMERICA DNA SEQUENCING PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 11 NORTH AMERICA DNA SEQUENCING OTHER END-USER MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 12 NORTH AMERICA DNA SEQUENCING MARKET BY TECHNOLOGY 2017-2023 ($ MILLION)
TABLE 13 SBS (SEQUENCING BY SYNTHESIS) PARAMETERS (ILLUMINA)
TABLE 14 NORTH AMERICA ILLUMINA SYNTHESIS MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 15 ION SEMICONDUCTOR SEQUENCING PARAMETERS (ION TORRENT SEQUENCING)
TABLE 16 NORTH AMERICA ION SEMICONDUCTOR SEQUENCING MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 17 SBL (SEQUENCING BY LITIGATION) PARAMETERS (SOLID SEQUENCING)
TABLE 18 NORTH AMERICA SEQUENCING BY LIGATION (SBL) MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 19 MICROBIAL APPLICATIONS USING PYROSEQUENCING
TABLE 20 PROS AND CONS OF PYROSEQUENCING
TABLE 21 NORTH AMERICA PYROSEQUENCING MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 22 SINGLE MOLECULE REAL TIME SEQUENCING PARAMETERS (PACIFIC BIOSCIENCES)
TABLE 23 NORTH AMERICA SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 24 NORTH AMERICA OTHER TECHNOLOGIES MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 25 NORTH AMERICA DNA SEQUENCING MARKET BY APPLICATION 2017-2023 ($ MILLION)
TABLE 26 FDA-APPROVED DRUGS ALONG WITH A COMPANION DIAGNOSTIC
TABLE 27 NORTH AMERICA DNA SEQUENCING DIAGNOSTICS MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 28 NORTH AMERICA DNA SEQUENCING DRUG DISCOVERY MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 29 NORTH AMERICA DNA SEQUENCING BIOMARKER DISCOVERY MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 30 NORTH AMERICA DNA SEQUENCING PERSONALIZED MEDICINE MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 31 NORTH AMERICA DNA SEQUENCING AGRICULTURE & ANIMAL RESEARCH MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 32 NORTH AMERICA DNA SEQUENCING OTHER APPLICATIONS MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 33 NORTH AMERICA DNA SEQUENCING MARKET BY GEOGRAPHY 2017-2023 ($ MILLION)
TABLE 34 DIABETES BY AGE GROUP IN CANADA IN 2014
TABLE 35 NORTH AMERICA DNA SEQUENCING MARKET 2017-2023($ MILLION)
TABLE 36 STATISTICS OF CANCER CASES IN US
LIST OF FIGURES
FIGURE 1 NORTH AMERICA DNA SEQUENCING MARKET 2017-2023 ($ MILLION)
FIGURE 2 NORTH AMERICA DNA SEQUENCING MARKET BY GEOGRAPHY 2016 ($ MILLION)
FIGURE 3 NORTH AMERICA DNA SEQUENCING MARKET SHARE ANALYSIS 2016
FIGURE 4 PORTER FIVE MODEL NORTH AMERICA DNA SEQUENCING MARKET
FIGURE 5 LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING
FIGURE 6 NORTH AMERICA DNA SEQUENCING MARKET BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2017-2023 ($ MILLION)
FIGURE 7 NORTH AMERICA DNA SEQUENCING MARKET BY HOSPITALS & CLINICS 2017-2023 ($ MILLION)
FIGURE 8 NORTH AMERICA DNA SEQUENCING MARKET BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 2017-2023 ($ MILLION)
FIGURE 9 BIOTECHNOLOGICAL TOOLS USED FOR THE CROP PROTECTION
FIGURE 10 NORTH AMERICA DNA SEQUENCING MARKET BY OTHER END-USER 2017-2023 ($ MILLION)
FIGURE 11 NORTH AMERICA DNA SEQUENCING MARKET BY ILLUMINA SYNTHESIS 2017-2023 ($ MILLION)
FIGURE 12 NORTH AMERICA DNA SEQUENCING MARKET BY ION SEMICONDUCTOR SEQUENCING 2017-2023 ($ MILLION)
FIGURE 13 NORTH AMERICA DNA SEQUENCING MARKET BY SEQUENCING BY LIGATION (SBL) 2017-2023 ($ MILLION)
FIGURE 14 NORTH AMERICA DNA SEQUENCING MARKET BY PYROSEQUENCING 2017-2023 ($ MILLION)
FIGURE 15 NORTH AMERICA DNA SEQUENCING MARKET BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2017-2023 ($ MILLION)
FIGURE 16 NORTH AMERICA DNA SEQUENCING MARKET BY OTHER TECHNOLOGIES 2017-2023 ($ MILLION)
FIGURE 17 NORTH AMERICA DNA SEQUENCING MARKET BY DIAGNOSTICS 2017-2023 ($ MILLION)
FIGURE 18 NORTH AMERICA DNA SEQUENCING MARKET BY DRUG DISCOVERY 2017-2023 ($ MILLION)
FIGURE 19 NORTH AMERICA DNA SEQUENCING MARKET BY BIOMARKER DISCOVERY 2017-2023 ($ MILLION)
FIGURE 20 PERSONALIZED MEDICINE BY APPLICATION AREAS 2014
FIGURE 21 NORTH AMERICA DNA SEQUENCING MARKET BY PERSONALIZED MEDICINE 2017-2023 ($ MILLION)
FIGURE 22 NORTH AMERICA DNA SEQUENCING MARKET BY AGRICULTURE & ANIMAL RESEARCH 2017-2023 ($ MILLION)
FIGURE 23 NORTH AMERICA DNA SEQUENCING MARKET BY OTHER APPLICATIONS 2017-2023 ($ MILLION)
FIGURE 24 NUMBER OF CANCER CASES AND DEATHS IN US FOR 2016
FIGURE 25 PREVALENCE OF DIABETES IN CANADA IN 2015 & 2025 (MILLION)
FIGURE 26 UNITED STATES NORTH AMERICA DNA SEQUENCING MARKET 2017-2023 ($ MILLION)
FIGURE 27 CANADA DNA SEQUENCING MARKET 2017-2023 ($ MILLION)
FIGURE 28 APPLICATIONS OF DNA MARKERS IN PLANT BREEDING
FIGURE 29 PROPORTIONAL MORTALITY (% OF TOTAL DEATHS) IN SOUTH AFRICA 2014
FIGURE 30 AFRICA DNA SEQUENCING MARKET 2017-2023 ($ MILLION)
FIGURE 1 NORTH AMERICA DNA SEQUENCING MARKET 2017-2023 ($ MILLION)
FIGURE 2 NORTH AMERICA DNA SEQUENCING MARKET BY GEOGRAPHY 2016 ($ MILLION)
FIGURE 3 NORTH AMERICA DNA SEQUENCING MARKET SHARE ANALYSIS 2016
FIGURE 4 PORTER FIVE MODEL NORTH AMERICA DNA SEQUENCING MARKET
FIGURE 5 LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING
FIGURE 6 NORTH AMERICA DNA SEQUENCING MARKET BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2017-2023 ($ MILLION)
FIGURE 7 NORTH AMERICA DNA SEQUENCING MARKET BY HOSPITALS & CLINICS 2017-2023 ($ MILLION)
FIGURE 8 NORTH AMERICA DNA SEQUENCING MARKET BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 2017-2023 ($ MILLION)
FIGURE 9 BIOTECHNOLOGICAL TOOLS USED FOR THE CROP PROTECTION
FIGURE 10 NORTH AMERICA DNA SEQUENCING MARKET BY OTHER END-USER 2017-2023 ($ MILLION)
FIGURE 11 NORTH AMERICA DNA SEQUENCING MARKET BY ILLUMINA SYNTHESIS 2017-2023 ($ MILLION)
FIGURE 12 NORTH AMERICA DNA SEQUENCING MARKET BY ION SEMICONDUCTOR SEQUENCING 2017-2023 ($ MILLION)
FIGURE 13 NORTH AMERICA DNA SEQUENCING MARKET BY SEQUENCING BY LIGATION (SBL) 2017-2023 ($ MILLION)
FIGURE 14 NORTH AMERICA DNA SEQUENCING MARKET BY PYROSEQUENCING 2017-2023 ($ MILLION)
FIGURE 15 NORTH AMERICA DNA SEQUENCING MARKET BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2017-2023 ($ MILLION)
FIGURE 16 NORTH AMERICA DNA SEQUENCING MARKET BY OTHER TECHNOLOGIES 2017-2023 ($ MILLION)
FIGURE 17 NORTH AMERICA DNA SEQUENCING MARKET BY DIAGNOSTICS 2017-2023 ($ MILLION)
FIGURE 18 NORTH AMERICA DNA SEQUENCING MARKET BY DRUG DISCOVERY 2017-2023 ($ MILLION)
FIGURE 19 NORTH AMERICA DNA SEQUENCING MARKET BY BIOMARKER DISCOVERY 2017-2023 ($ MILLION)
FIGURE 20 PERSONALIZED MEDICINE BY APPLICATION AREAS 2014
FIGURE 21 NORTH AMERICA DNA SEQUENCING MARKET BY PERSONALIZED MEDICINE 2017-2023 ($ MILLION)
FIGURE 22 NORTH AMERICA DNA SEQUENCING MARKET BY AGRICULTURE & ANIMAL RESEARCH 2017-2023 ($ MILLION)
FIGURE 23 NORTH AMERICA DNA SEQUENCING MARKET BY OTHER APPLICATIONS 2017-2023 ($ MILLION)
FIGURE 24 NUMBER OF CANCER CASES AND DEATHS IN US FOR 2016
FIGURE 25 PREVALENCE OF DIABETES IN CANADA IN 2015 & 2025 (MILLION)
FIGURE 26 UNITED STATES NORTH AMERICA DNA SEQUENCING MARKET 2017-2023 ($ MILLION)
FIGURE 27 CANADA DNA SEQUENCING MARKET 2017-2023 ($ MILLION)
FIGURE 28 APPLICATIONS OF DNA MARKERS IN PLANT BREEDING
FIGURE 29 PROPORTIONAL MORTALITY (% OF TOTAL DEATHS) IN SOUTH AFRICA 2014
FIGURE 30 AFRICA DNA SEQUENCING MARKET 2017-2023 ($ MILLION)
